Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Olja Stevanovic"'
Autor:
Ivana Milosevic, Nevena Todorovic, Ana Filipovic, Jelena Simic, Marko Markovic, Olja Stevanovic, Jovan Malinic, Natasa Katanic, Nikola Mitrovic, Natasa Nikolic
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16048 (2023)
Hepatitis C virus (HCV) is a major cause of hepatocellular carcinoma (HCC) accounting for around one-third of all HCC cases. Prolonged inflammation in chronic hepatitis C (CHC), maintained through a variety of pro- and anti-inflammatory mediators, is
Externí odkaz:
https://doaj.org/article/f0860bbfc9ff46fd958c2f0289147821
Autor:
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 2, p 395 (2019)
The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the new virtual metabolic organ”, makes axis with a number of
Externí odkaz:
https://doaj.org/article/c09569608e81425890fa70c3f6f9b610
Autor:
Olja Stevanovic, Ivana Milosevic, Edda Russo, Amedeo Amedei, Stefano Gitto, Ankica Vujovic, Aleksandra Barac
Publikováno v:
World Journal of Gastroenterology
Changes in gut microbiota influence both the gut and liver, which are strictly connected by the so-called “gut–liver axis”. The gut microbiota acts as a major determinant of this relationship in the onset and clinical course of liver diseases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e57786b62ad58665dc14a378745d2228
https://doi.org/10.3748/wjg.v27.i33.5488
https://doi.org/10.3748/wjg.v27.i33.5488
Publikováno v:
Journal of infection in developing countries, 14(11):1248-1251
We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3122b0bf107c6950aa83828a297d8af6
https://doi.org/10.3855/jidc.13840
https://doi.org/10.3855/jidc.13840
Autor:
Olga Petrovic, Olja Stevanovic, Arsen Ristić, Ivana Milosevic, Aleksandra Radovanovic Spurnic, Danilo Obradovic, Ivana Gmizic
Publikováno v:
The Journal of Infection in Developing Countries. 13:352-356
Streptococcus gallolyticus (S. gallolyticus) bacteremia is commonly associated with endocarditis and diseases of gastrointestinal tract, especially with colorectal carcinoma. On the other side, it is rarely connected to liver disease, especially alco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d871613bee5c33b42b3e9cbb7f2921e0
https://doi.org/10.3855/jidc.11126
https://doi.org/10.3855/jidc.11126
Autor:
Ankica Vujovic, Edda Russo, Vladimir Djordjevic, Aleksandra Barac, Nebojsa Lekic, Olja Stevanovic, Ivana Milosevic, Ivana Gmizic, Amedeo Amedei, Aleksandra Radovanovic Spurnic, Milos Korac, Marina Djelic
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 2, p 395 (2019)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the new virtual metabolic organ”, makes axis with a number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3aa7812200e03df7296f023b3ac712b
http://hdl.handle.net/2158/1172466
http://hdl.handle.net/2158/1172466
Autor:
Aleksandra Barac, Aleksandra Arsenović, Olja Stevanovic, Goran Stevanovic, Branko Brmbolic, Ivana Milosevic, Marijana Smiljanić, Miljana Đonin-Nenezić, Ivana Pesic-Pavlovic, Uroš Karić
Publikováno v:
Journal of infection in developing countries. 12(2)
We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14912d22e93790f602306453eb6961d8
https://pubmed.ncbi.nlm.nih.gov/31825917
https://pubmed.ncbi.nlm.nih.gov/31825917